Activation of the body’s CB2 receptors, something done naturally through the consumption of cannabis, is a “useful therapeutic approach for Alzheimer’s disease”, according to a new study.
“Alzheimer’s disease is a multifactorial disorder for which there is no disease-modifying treatment yet”, states the abstract of the study, published in the journal CNS Drugs. “CB2 receptors have emerged as a promising therapeutic target for Alzheimer’s disease because they are expressed in neuronal and glial cells and their activation has no psychoactive effects.”
The aim of this study was “to investigate whether activation of the CB2 receptor would restore the aberrant enhanced proliferative activity characteristic of immortalized lymphocytes from patients with late-onset Alzheimer’s disease. It is assumed that cell-cycle dysfunction occurs in both peripheral cells and neurons in patients with Alzheimer’s disease, contributing to the instigation of the disease.”